AAD's Dialogues in Dermatology

Sylvia L. Parra, MD, FAAD interviewed by Elisa S. Gallo, MD, FAAD

As Medicare continues its shift toward value-based care, understanding how to participate in MIPS is increasingly important for dermatology practices. Hear from Sylvia Parra, MD, FAAD and Elisa S. Gallo, MD, FAAD as they discuss how dermatologists can approach 2026 reporting with greater confidence and prepare for the growing role of MIPS Value Pathways.

Auris Huen, PharmD, MD, FAAD interviewed by Alyx Cali Rosen Aigen, MD, FAAD

Cutaneous T-cell lymphoma can be difficult to recognize, particularly when it resembles more common inflammatory skin conditions. Hear from Auris Huen, PharmD, MD, FAAD and Alyx Cali Rosen Aigen, MD, FAAD as they discuss how recognizing subtle clinical clues can help dermatologists identify CTCL earlier and improve the path to diagnosis.

Curtis Asbury, MD, FAAD interviewed by Roman Bronfenbrener, MD, FAAD

N/A

Matilda Wray Nicholas, MD, PhD, FAAD interviewed by Alyx Cali Rosen Aigen, MD, FAAD

Systemic mastocytosis can present with a wide range of cutaneous and systemic findings, making early recognition particularly important for dermatologists. Join Matilda Wray Nicholas, MD, PhD, FAAD and Alyx Cali Rosen Aigen, MD, FAAD as they discuss how dermatologists can recognize mastocytosis and guide patients through appropriate evaluation and management.This episode is sponsored by Blueprint Medicines. The American Academy of Dermatology retains control over the episode content and interview participant selection.

Lindsey Bordone, MD, FAAD interviewed by Sabrina Shearer, MD, FAAD

Obesity can influence inflammatory skin disease in ways that directly affect both disease severity and response to treatment. Join Lindsey Bordone, MD, FAAD and Sabrina Shearer, MD, FAAD as they discuss why addressing obesity may be an important part of comprehensive dermatologic care.This episode is sponsored by Ortho Dermatologics. The American Academy of Dermatology retains control over the episode content and interview participant selection.

View episode transcript

Mollie A. MacCormack, MD, FAAD interviewed by Brad P. Glick, DO, MPH, FAAD

N/A

Brad P. Glick, DO, MPH, FAAD interviewed by David T. Harvey, MD, FAAD

N/A

Daniel Eisen, MD, FAAD and Martina J Porter, MD, FAAD interviewed by Olayemi Sokumbi, MD, FAAD

This episode is supported by Novartis. The American Academy of Dermatology retains control over the episode content and interview participant selection.

View episode transcript

Daniel Eisen, MD, FAAD and Martina J Porter, MD, FAAD interviewed by Olayemi Sokumbi, MD, FAAD

This episode is supported by Novartis. The American Academy of Dermatology retains control over the episode content and interview participant selection.

View episode transcript

Kelly Cordoro, MD interviewed by Robert Smith, MD, FAAD

Psoriasis in children can carry a significant burden that extends well beyond the visible signs of disease. Hear from Kelly Cordoro, MD and Robert Smith, MD, FAAD as they discuss how an individualized approach to treatment can better address the needs of pediatric patients and their families.This episode has been sponsored by Johnson & Johnson.

View episode transcript